VolitionRX
150 Orchard Road
Orchard Plaza 08-02
Singapore
238841
Website: http://www.volitionrx.com/
Email: info@volitionrx.com
265 articles about VolitionRX
-
VolitionRX Announces Appointment Of David Kratochvil As Chief Financial Officer
8/17/2015
-
VolitionRX Announces Second Quarter 2015 Financial Results And Business Update
8/11/2015
-
VolitionRX Schedules Second Quarter 2015 Earnings Conference Call And Business Update For Tuesday, August 11, 2015 At 8:30am ET
8/5/2015
-
VolitionRX To Present At Wedbush PacGrow Healthcare Conference
8/3/2015
-
VolitionRX Engages Specialty Clinical Research Organization To Support Initial Entry Of Its Nuq Colorectal Cancer Tests Via U.S. CLIA Labs
7/27/2015
-
VolitionRX CSO Dr. Jake Micallef To Present Scientific Webinar
7/8/2015
-
VolitionRX Expands Scientific Advisory Board
7/6/2015
-
VolitionRX Partners With Two Market Access Consulting Agencies To Support Market Access Of NuQ Colorectal Cancer Tests In Europe
6/23/2015
-
VolitionRX To Present At Two Upcoming Investor Conferences
5/19/2015
-
VolitionRX CEO Cameron Reynolds To Present Informational Webinar
5/18/2015
-
VolitionRX Announces First Quarter 2015 Financial Results And Business Update
5/12/2015
-
VolitionRX Accelerates Clinical Trial With University Hospital Bonn, Germany Evaluating NuQ Assays In Most Prevalent Cancers
5/8/2015
-
VolitionRX Schedules First Quarter 2015 Earnings Conference Call And Business Update For Tuesday, May 12, 2015 At 8:30 A.M. ET
5/6/2015
-
VolitionRX Initiates Study With Hvidovre Hospital, Denmark, Specifically To Target NuQ Biomarker Panel For Colorectal Polyps
4/21/2015
-
VolitionRX Adds Three New Laboratory Automation Systems To Expedite Sample Analysis For Its Large Ongoing Clinical Trials
4/9/2015
-
VolitionRX Initiates Second Prostate Cancer Pilot Study Assessing Nucleosomics(R) Technology
3/5/2015
-
VolitionRX Acquires Direct Ownership Of Nucleosomics Technology Patent
2/24/2015
-
VolitionRX Announces Exercise Of Over-Allotment Option In Previously Announced Public Offering
2/17/2015
-
VolitionRX Announces Closing Of Public Offering Of Common Stock
2/12/2015
-
VolitionRX Prices Public Offering of Common Stock
2/6/2015